Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Men with testicular cancer were less likely to experience baldness and severe acne.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

New treatments for PCOS focus on managing symptoms and improving fertility.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Young women with PCOS and no other heart risk factors have normal heart function.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Altering SSAT affects fat metabolism and body fat in mice.

Sebum from sebocytes is important for skin health and linked to conditions like acne and hair loss.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.